As one presenter mentioned, the moment whenthe CAR-T Therapy moves from academic discovery to industrial development, itis not the end of developing but the starting point. Similarly, the firstapproval of CAR-T therapy officially endorsed the people's efforts over lasttwo decades, Gilead purchase of Kite confirmed the value of this sector, yet westill have the long way to go, but with better knowledge and more courage.

11月17日国际细胞治疗上海峰会，30多位国际顶级的药政专家、临床KOL、知名企业C-level高管、投资人、顶级律所专利律师，将从技术、生产、监管、知识产权、企业融资发展等各个角度为大家带来精彩主题分享。会议详情请见：全球CAR-T专家齐聚上海，共演细胞治疗巅峰盛会。